Novartis Pharma The Business Unit Model Case Solution

Case Solution

In June 2000, Novartis reorganized its pharmaceutical business to produce global business models in oncology, transplantation, ophthalmology, and mature products. The relaxation from the primary care products ongoing being handled within global functions (e.g., R&D and marketing). The completely new organization created a matrix structure and new roles and responsibilities for heads of business functions, CEO's of latest business models, and country managers operating in over 100 nations.

Excel Calculations

Questions Covered

Form of Business Units Created at Novartis Pharmaceuticals

Creation of Marketing Focus

Quick Response to Changes in Market Dynamics

Inculcation of Entrepreneurial Spirit and Motivation of Staff

Creation of Reporting Conflicts

Less Focus on Long-Term Research and Development

Conclusion